Anzeige
Mehr »
Login
Montag, 23.11.2020 Börsentäglich über 12.000 News von 647 internationalen Medien
"Durchbruchsmeldung"! Kommt heute noch ein richtiger Höhenflug?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 857031 ISIN: JP3205800000 Ticker-Symbol: KAO 
Tradegate
23.11.20
15:06 Uhr
65,00 Euro
+1,00
+1,56 %
Branche
Konsumgüter
Aktienmarkt
NIKKEI-225
1-Jahres-Chart
KAO CORPORATION Chart 1 Jahr
5-Tage-Chart
KAO CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
64,0066,0016:38
64,5066,0016:40
GlobeNewswire (Europe)
1.412 Leser
Artikel bewerten:
(2)

Oil-Dri Corporation Of America: Fred Kao Named Vice President of Global Sales for Amlan International

CHICAGO, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Amlan International, a global leader in developing innovative solutions that improve livestock intestinal health and productivity, is proud to name Fred H. Kao for the new role of Vice President of Global Sales.

The creation of this position further supports the company's investment in the gut health product line for the global market. Driven by increasing consumer demand for protein produced without antibiotics, Amlan International is excited to move confidently forward to provide animal health solutions for their customers.

Kao brings to the company 20 years of expertise in building strong relationships with key integrators in the animal protein business. Kao has worked in Europe, Middle East, African and Asia Pacific regions since 2004. He most recently managed the Asia Pacific business unit for Cobb-Vantress Inc.

In the span of just two years, Kao oversaw changes in the Cobb-Vantress business operations in China that led to significant profitability for the company. He structured operations in the Philippines for long term growth and oversaw the development of Cobb's New Zealand project.

"Fred H. Kao's ability to create relationships with the sales team as well as key integrators will position Amlan International to achieve new heights in emerging markets," says Flemming L. Mahs, President of Amlan International. "Fred is a generator of new ideas and an innovative new business developer. Amlan's growing global sales team is essential to match the demand for our products worldwide. With his leadership, Amlan will be well-positioned to meet the demands of livestock producers for natural alternatives to antibiotic growth promoters and intestinal health."

Prior to his work with Cobb-Vantress, Kao worked for more than 16 years for Aviagen Inc. where he managed a team of eight commercial and technical managers and more than doubled the responsible brand's worldwide Parent Stock shares.

Kao is a 2000 graduate of the University of Arkansas. He is fluent in Mandarin and Cantonese and competent in two other languages (Japanese and Spanish), which is an important asset to connecting with a diverse and growing customer base.

Amlan International

Oil-Dri Corporation of America (NYSE: ODC), a Delaware corporation doing business as "Amlan International," is a global leader in proven solutions that improve the intestinal health and productivity of livestock. Amlan has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted at its laboratory campus in Vernon Hills, Illinois. Flemming L. Mahs is President of Amlan International, a subsidiary of Oil-Dri Corporation of America.

Amlan International sells animal health products outside of the United States. Product associated claims do not constitute medical claims and may differ based on government requirements. Product availability may vary by country.

Reagan Culbertson
Media Contact
press@amlan.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e1bd733f-368d-4b9c-a60c-229255e9336a

KAO-Aktie komplett kostenlos handeln - auf Smartbroker.de
© 2020 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.